Furthermore, the effect of TREK–1 in IPF was described by using public database GSE110147, including lung samples from 22 IPF patients undergoing lung transplantation and 11 normal lung tissues surrounding lung cancer resections. The gene discussed is KCNK2; the disease is lung carcinoma.